Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Pyridines > Nicotinic Acids > 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
Heterocyclic Compounds > Acids, Heterocyclic > Nicotinic Acids > 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Pyridines > Dihydropyridines > 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester

Preferred term

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • Bay K 8644
  • Bay-K-8644
  • BayK8644
  • Bay-K-8644, (+)-Isomer
  • Bay-K-8644, (+-)-Isomer
  • Bay-K-8644, (-)-Isomer
  • Bay R 5417
  • Bay-R-5417
  • BayR5417

Note

  • a calcium channel agonist

Scope note

  • A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool.

History note

  • 87

In other languages

URI

http://www.yso.fi/onto/mesh/D001498

Download this concept:

RDF/XML TURTLE JSON-LD Created 6/2/86, last modified 5/27/16